US Oncology, which helps manage Cancer Centers of North Carolina, agreed to be bought for $2.16 billion by drug distributor McKesson.
Texas-based US Oncology provides services and supplies to more than 1,300 oncologists across the country, including access to clinical research.
In this market, that includes an affiliation with Cancer Centers of North Carolina, which has clinics in Raleigh, Cary, Clayton and Dunn. That group, established as Raleigh Hematology Oncology Associates in 1979 by Dr. William Berry, affiliated with US Oncology in 1995.
The McKesson deal is the latest tied to changes coming under the federal health overhaul, including cuts in reimbursement by Medicare and Medicaid. While patients won't notice much change for now, new affiliations and business agreements could reshape much of the industry.